Stockreport

Xoma to acquire Kinnate Biopharma for $2.3352 - $2.5879 per share [Seeking Alpha]

Kinnate Biopharma Inc.  (KNTE) 
PDF Kinnate Biopharma ( NASDAQ: KNTE ) for $2.3352–$2.5879 per share in cash plus a contingent value right. Per the terms, the deal indicates a base price of $2.3352 per s [Read more]